Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study

Background Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide.Methods A multimethods analysis was performed as part of the GlobalSurg 3 study-a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital.Findings Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3.85 [95% CI 2.58-5.75]; p<0.0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63.0% vs 82.7%; OR 0.35 [0.23-0.53]; p<0.0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer.Interpretation Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised

Avaliação qualitativa do efeito de agentes de limpeza na camada de lama dentinária: estudo ultra-estrutural em microscopia eletrônica de varredura

Quando qualquer instrumento abrasiona ou corta a dentina, produz na superfície uma camada de lama dentinária ou smear layer. Dependendo do agente de união indicado em Odontologia adesiva, há a necessidade ou não da remoção da camada de lama da superfície dentinária. Com a finalidade de verificar a ação de diferentes substâncias para a limpeza dentinária, utilizamos 20 dentes pré-molares superiores íntegros, mantidos em soro fisiológico, nos quais as coroas foram seccionadas ao meio no sentido mésio-distal. Com instrumento diamantado, removeu-se o esmalte da porção vestibular e da porção lingual da coroa e, com uma broca carbide cilíndrica lisa nº 56, cortou-se aproximadamente 1 mm de dentina com alta rotação sob abundante refrigeração ar/água, para produzir a camada de lama dentinária. em seguida, essa superfície foi tratada com diferentes substâncias e lavada por 30 segundos com spray ar/água. No controle, foi simplesmente utilizado o spray ar/água. Os espécimes foram montados em suportes metálicos, preparados e visualizados no MEV-DSM 950 da Zeiss, em aumentos que variaram de 100 a 5.000 vezes. Os materiais que mais removeram a camada de lama foram, em ordem crescente: 1. spray ar/água; 2. fluoreto de sódio 2%; 3. associação alternada de Dakin/Tergensol; 4. água oxigenada 3%; 5. jateamento com óxido de alumínio 50 mm; 6. flúor acidulado 1,27%; 7. ácido poliacrílico 25%; 8. ácido fosfórico 10%.A smear layer is produced on the dentin surface after abrasion or cutting by instruments. Its removal is indicated or not according to the kind of bonding agent used in adhesive dentistry. The purpose of this study was to evaluate the possible effects of some substances on the smear layer. Twenty upper non-carious premolars, stored in isotonic saline solution, were mesiodistally hemi-sectioned and the buccal and lingual enamel was removed with high speed diamond bur. One millimeter of the dentinal surface was then removed with a water-cooled high speed carbide bur # 56 in order to obtain the smear layer. Different solutions were applied on the dentin surface for 30 seconds, which was then rinsed and dried. The specimens were mounted on metallic holder stubs, prepared, and examined under the scanning electron microscope (DSM 95-Zeiss). Removal of the smear layer by the tested solutions was qualitatively observed, and the solutions, rated according to their performance in increasing order of extent of removal, as follows: 1. air/water spray; 2. 2% NaF; 3. sodium hypochloride/anodic detergent; 4. 3% H2O2; 5. sandblasting with 50 mm aluminum oxide; 6. 1.27% acidulated fluoride; 7. 25% polyacrylic acid; 8. 10% phosphoric acid. The best solutions for the removal of the smear layer were the acid ones

Avaliação clínica de vinte e quatro meses do Fluroshield e do Vitremer utilizados como selante de fossas e fissuras

Avaliou-se o desempenho de dois materiais utilizados como selante oclusal (Fluroshield e Vitremer). Foram selados 46 pré-molares, superiores e/ou inferiores, sem sinais clínicos de lesões de cárie, sendo que 23 dentes foram selados com Vitremer e 23 com Fluroshield. Após seis, doze e vinte e quatro meses de acompanhamento, observou-se que o Vitremer apresentou uma retenção total de 91,30%, 91,30% e 82,60%, enquanto o Fluroshield apresentou 100% de retenção total nos três intervalos de tempo. Ambos os materiais impediram o desenvolvimento de lesões de cárie, independente de sua retenção e períodos avaliados.The clinical performance of two dental materials used as pit and fissure sealants (Fluroshield and Vitremer) was evaluated. Forty-six sound upper or lower premolars were sealed. Twenty-three teeth were sealed with Vitremer and 23 with Fluroshield. After six, twelve, and twenty-four months Vitremer presented a total retention of 91.30%, 91.30%, and 82.60%, and Fluroshield presented a total retention of 100% in the three periods of evaluation. Both materials do not permit the development of caries, independent of their retention and period of evaluation

DESENVOLVIMENTO DE UMA ESCALA EM SILICONA PARA TONS DE PELE HUMANA DEVELOPMENT OF A SILICONE SCALE FOR SHADES OF HUMAN SKIN

O autor desenvolveu em silicona uma escala de tonalidades de pele humana. Foram confeccionados vinte e sete corpos-de-prova em silicona acética (Silastic 732 RTV), pigmentados com óxidos de ferro e dióxido de titânio. A quantidade de silicona acética manteve-se constante (dois gramas) em todos os corpos-de-prova, e os pigmentos foram misturados a ela em várias proporções até a obtenção de vinte e sete diferentes tonalidades. Através da comparação da cor dos corpos-de-prova com a cor da pele de quarenta e um indivíduos, foram selecionados os cinco corpos-de-prova com as tonalidades que mais se igualavam à cor da pele dos pacientes, compondo, assim, um guia de tonalidades. Com a metodologia empregada, foi possível desenvolver uma escala de tonalidades de pele que poderá facilitar a definição do tom da pele do paciente quando da confecção de próteses faciais em silicona, permitindo economia de tempo e de material no momento da seleção da cor.<br>The author developed a scale in silicone of shades of human skin. Twenty-seven samples were produced in acetic silicone (Silastic 732 RTV), pigmented with iron oxides and titanium dioxide. The amount of acetic silicone was kept constant (two grams) in all of the samples, and the pigments were mixed to it in varying proportions, until twenty-seven different shades were obtained. By comparing the color of the samples with the skin color of forty-one individuals, five samples were selected of the shades that best matched a patient's color of skin to form a shade guide. With the methodology employed, it was possible to develop a shade guide that will facilitate a definition of a patient's skin color in producing facial prostheses in silicone, to afford economy in time and in material at time for selecting the color

Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries

Background: 80% of individuals with cancer will require a surgical procedure, yet little comparative data exist on early outcomes in low-income and middle-income countries (LMICs). We compared postoperative outcomes in breast, colorectal, and gastric cancer surgery in hospitals worldwide, focusing on the effect of disease stage and complications on postoperative mortality. Methods: This was a multicentre, international prospective cohort study of consecutive adult patients undergoing surgery for primary breast, colorectal, or gastric cancer requiring a skin incision done under general or neuraxial anaesthesia. The primary outcome was death or major complication within 30 days of surgery. Multilevel logistic regression determined relationships within three-level nested models of patients within hospitals and countries. Hospital-level infrastructure effects were explored with three-way mediation analyses. This study was registered with ClinicalTrials.gov, NCT03471494. Findings: Between April 1, 2018, and Jan 31, 2019, we enrolled 15 958 patients from 428 hospitals in 82 countries (high income 9106 patients, 31 countries; upper-middle income 2721 patients, 23 countries; or lower-middle income 4131 patients, 28 countries). Patients in LMICs presented with more advanced disease compared with patients in high-income countries. 30-day mortality was higher for gastric cancer in low-income or lower-middle-income countries (adjusted odds ratio 3·72, 95% CI 1·70–8·16) and for colorectal cancer in low-income or lower-middle-income countries (4·59, 2·39–8·80) and upper-middle-income countries (2·06, 1·11–3·83). No difference in 30-day mortality was seen in breast cancer. The proportion of patients who died after a major complication was greatest in low-income or lower-middle-income countries (6·15, 3·26–11·59) and upper-middle-income countries (3·89, 2·08–7·29). Postoperative death after complications was partly explained by patient factors (60%) and partly by hospital or country (40%). The absence of consistently available postoperative care facilities was associated with seven to 10 more deaths per 100 major complications in LMICs. Cancer stage alone explained little of the early variation in mortality or postoperative complications. Interpretation: Higher levels of mortality after cancer surgery in LMICs was not fully explained by later presentation of disease. The capacity to rescue patients from surgical complications is a tangible opportunity for meaningful intervention. Early death after cancer surgery might be reduced by policies focusing on strengthening perioperative care systems to detect and intervene in common complications. Funding: National Institute for Health Research Global Health Research Unit

Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries

© 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 licenseBackground: 80% of individuals with cancer will require a surgical procedure, yet little comparative data exist on early outcomes in low-income and middle-income countries (LMICs). We compared postoperative outcomes in breast, colorectal, and gastric cancer surgery in hospitals worldwide, focusing on the effect of disease stage and complications on postoperative mortality. Methods: This was a multicentre, international prospective cohort study of consecutive adult patients undergoing surgery for primary breast, colorectal, or gastric cancer requiring a skin incision done under general or neuraxial anaesthesia. The primary outcome was death or major complication within 30 days of surgery. Multilevel logistic regression determined relationships within three-level nested models of patients within hospitals and countries. Hospital-level infrastructure effects were explored with three-way mediation analyses. This study was registered with ClinicalTrials.gov, NCT03471494. Findings: Between April 1, 2018, and Jan 31, 2019, we enrolled 15 958 patients from 428 hospitals in 82 countries (high income 9106 patients, 31 countries; upper-middle income 2721 patients, 23 countries; or lower-middle income 4131 patients, 28 countries). Patients in LMICs presented with more advanced disease compared with patients in high-income countries. 30-day mortality was higher for gastric cancer in low-income or lower-middle-income countries (adjusted odds ratio 3·72, 95% CI 1·70–8·16) and for colorectal cancer in low-income or lower-middle-income countries (4·59, 2·39–8·80) and upper-middle-income countries (2·06, 1·11–3·83). No difference in 30-day mortality was seen in breast cancer. The proportion of patients who died after a major complication was greatest in low-income or lower-middle-income countries (6·15, 3·26–11·59) and upper-middle-income countries (3·89, 2·08–7·29). Postoperative death after complications was partly explained by patient factors (60%) and partly by hospital or country (40%). The absence of consistently available postoperative care facilities was associated with seven to 10 more deaths per 100 major complications in LMICs. Cancer stage alone explained little of the early variation in mortality or postoperative complications. Interpretation: Higher levels of mortality after cancer surgery in LMICs was not fully explained by later presentation of disease. The capacity to rescue patients from surgical complications is a tangible opportunity for meaningful intervention. Early death after cancer surgery might be reduced by policies focusing on strengthening perioperative care systems to detect and intervene in common complications. Funding: National Institute for Health Research Global Health Research Unit